A new Perspective article published in the New England Journal of Medicine emphasizes the critical role of Fracture Liaison Services (FLS) in addressing the growing global burden of osteoporosis-related fractures, particularly hip fractures.
Milestone’s plans to resubmit heart drug; Alvotech’s $166M offer; Vaccine biotech raises $11M
Milestone Pharmaceuticals details plan to resubmit etripamil to the FDA in Q2: For its experimental treatment for paroxysmal supraventricular tachycardia, the company will now “restructure